To direct the Secretary of Health and Human Services, acting through the Commissioner of Food and Drugs, to submit to Congress a report on barriers, including regulatory inefficiencies, to domestic manufacturing of active pharmaceutical ingredients, finished drug products, and devices, and for other purposes.

Cost and committee reports

Official records Congress.gov attaches to H.R. 6710.

• Constitutional authority statementThe sponsor’s statement of where the Constitution gives Congress the power to pass this bill. Statement by Ms. HERRELL, as printed in the Congressional Record (Vol. 168, No. 28, February 11, 2022, Page H1119):
  Article I, Section 8. To make laws which shall be necessary and proper for carrying into execution the foregoing powers, and all other powers vested by this Constitution in the government of the United States, or in any department or officer thereof.
  Source: Congress.gov, Congressional Record February 11, 2022 ↗

  Evidence

  Field in the Congress.gov record

  constitutionalAuthorityStatementText

  Statement length

  250 characters

  Congress.gov bill record

  H.R. 6710, 117th Congress

  Congress.gov API record

  https://api.congress.gov/v3/bill/117/hr/6710

  Record last updated by Congress.gov

  January 3, 2025

  PORKER copy retrieved

  September 16, 2026

  Stored copy, SHA-256 of the file

  5c767a457248a3e7fa602efba0c209e12fdaf51e91060b78b1ec97687b21e169

  PORKER shows the statement exactly as printed, with the page markup removed. It is the sponsor’s claim; it is not a legal finding.

Congress.gov’s record for this bill does not list a CBO cost estimate or a committee report (as of January 3, 2025). Not every bill gets one.

From the Congress.gov bill record for H.R. 6710, last updated January 3, 2025. PORKER’s copy was retrieved September 16, 2026 and is refreshed nightly. Open “Evidence” on any line for the record, field and file fingerprint.